FAPI PET Positivity in Fibrolamellar Hepatocellular Carcinoma.
Clin Nucl Med
; 48(7): e332-e333, 2023 Jul 01.
Article
in En
| MEDLINE
| ID: mdl-37075257
ABSTRACT
ABSTRACT Fibrolamellar hepatocellular carcinoma (HCC) is a variant of HCC. It is a malignant tumor, but its imaging features often overlap focal nodular hyperplasia, which is a benign entity. FDG PET/CT is also not much help in these cases because both lesions do not concentrate FDG. We present one such case of fibrolamellar HCC with FAPI PET/CT positivity.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Clin Nucl Med
Year:
2023
Document type:
Article
Publication country:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA